Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-09-03 4:48 pm Sale | 2026-09-03 | 13G | VIVOS THERAPEUTICS INC VVOS | Streeterville Capital LLC | 122,963 0.600% | -1,689,068 (-93.21%) | Filing History |
| 2026-08-14 10:29 am Sale | 2026-06-30 | 13G | VIVOS THERAPEUTICS INC VVOS | Armistice Capital, LLC | 729,755 4.990% | -386,104 (-34.60%) | Filing History |
| 2026-08-11 1:28 pm Purchase | 2026-08-11 | 13G | VIVOS THERAPEUTICS INC VVOS | Streeterville Capital LLC | 1,812,031 9.300% | 1,812,031 (New Position) | Filing History |
| 2026-07-15 5:07 pm Purchase | 2026-06-30 | 13D | VIVOS THERAPEUTICS INC VVOS | V-Co Investors 4 LLC | 2,783,102 19.900% | 2,783,102 (New Position) | Filing History |
| 2026-05-15 11:05 am Purchase | 2026-03-31 | 13G | VIVOS THERAPEUTICS INC VVOS | Armistice Capital, LLC | 1,115,859 8.270% | 865,582 (+345.85%) | Filing History |
| 2026-04-02 6:32 pm Purchase | 2026-03-31 | 13D | VIVOS THERAPEUTICS INC VVOS | V-Co Investors 3 LLC | 2,696,123 19.900% | 2,696,123 (New Position) | Filing History |
| 2025-07-14 1:36 pm Purchase | 2025-07-08 | 13G | VIVOS THERAPEUTICS INC VVOS | Dawei Luo | 572,016 8.520% | 572,016 (New Position) | Filing History |
| 2025-06-16 7:57 pm Purchase | 2025-06-09 | 13D | VIVOS THERAPEUTICS INC VVOS | V-CO Investors LLC | 1,342,498 19.900% | 828,000 (+160.93%) | Filing History |
| 2024-12-30 5:39 pm Purchase | 2024-12-22 | 13G | VIVOS THERAPEUTICS INC VVOS | Mitchell P. Kopin | 297,315 4.990% | 297,315 (New Position) | Filing History |
| 2024-12-20 3:17 pm Purchase | 2024-12-17 | 13G | VIVOS THERAPEUTICS INC VVOS | V-CO Investors LLC | 514,498 9.900% | 514,498 (New Position) | Filing History |
| 2024-11-14 4:49 pm Purchase | 2024-09-30 | 13G | VIVOS THERAPEUTICS INC VVOS | Armistice Capital, LLC | 250,277 4.990% | 75,178 (+42.93%) | Filing History |
| 2024-11-14 4:05 pm Sale | 2024-09-30 | 13G | VIVOS THERAPEUTICS INC VVOS | Ionic Ventures, LLC | 83,000 1.800% | -329,064 (-79.86%) | Filing History |
| 2024-09-24 2:59 pm Purchase | 2024-09-19 | 13G | VIVOS THERAPEUTICS INC VVOS | Ionic Ventures, LLC | 412,064 8.700% | 412,064 (New Position) | Filing History |
| 2024-02-14 5:42 pm Purchase | 2023-12-31 | 13G | VIVOS THERAPEUTICS INC VVOS | Huntsman Ronald Kirk | 94,794 4.300% | 4,761 (+5.29%) | Filing History |
| 2024-02-14 3:57 pm Purchase | 2023-12-31 | 13G | VIVOS THERAPEUTICS INC VVOS | Armistice Capital, LLC | 175,099 9.990% | 175,099 (New Position) | Filing History |
| 2023-02-10 4:05 pm Purchase | 2022-12-31 | 13G | VIVOS THERAPEUTICS INC VVOS | Huntsman Ronald Kirk | 90,033 9.000% | 1,480 (+1.67%) | Filing History |
| 2022-02-14 5:03 pm Purchase | 2021-12-31 | 13G | VIVOS THERAPEUTICS INC VVOS | Huntsman Ronald Kirk | 88,553 9.620% | 5,200 (+6.24%) | Filing History |
| 2022-02-14 5:02 pm Purchase | 2021-12-31 | 13G | VIVOS THERAPEUTICS INC VVOS | Singh Gurdev Dave | 129,988 14.100% | 1,200 (+0.93%) | Filing History |